Private device makers enjoy the biggest quarter for four years – and the average deal is larger than ever.
Digital therapeutics are going from strength to strength during the pandemic.
Ironwood signs up with the leading prescription app developer, but Pear is not to everyone’s taste.
Software can be a medical device. Can it also be a drug?